Clinical trial
Mechanisms of Weight Loss With SGLT2 Inhibition
NCT02360774
Study timeline
Study start (unknown)2015-02-01Date precision: month
Registry last updated2018-08-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
CanagliflozinDRUG · verified · RxNorm: canagliflozin
PlaceboDRUG
Sponsors & collaborators
Beth Israel Deaconess Medical Centerlead sponsor
Janssen Scientific Affairs, LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02360774 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.